Welcome, this website is intended for international healthcare professionals with an interest in the treatment of Advanced Prostate Cancer. By clicking the link below you are declaring and confirming that you are a healthcare professional

You are here

EAU 2014, INTERVIEW WITH PROF. TAMMELA

TAMMELA INTERVIEW 2 05 2014

Professor Teuvo Tammela, Professor and Chief of Urology, Division of Urology, Tampere University Hospital, Helsinki, Finland, presented "Safety and efficacy of ODM-201 in chemotherapy and CYP17-inhibitor naïve patients: Analysis of data from the ARADES and the ARAFOR trials".

The content of the videos, articles and all statements expressed therein do not necessarily reflect the opinions or views of the Editors, Authors or Reviewers of European Urology.